< Terug naar vorige pagina
Publicatie
Belgian consensus for Helicobacter pylori management 2023
Tijdschriftbijdrage - Tijdschriftartikel
Helicobacter pylori (H. pylori) infection causes
chronic gastritis, peptic ulcers and gastric cancer.
Although H. pylori prevalence is decreasing worldwide,
regional variations exist in Europe, with the lowest
infection prevalence in Northern Europe, and the highest
in Eastern and Southern Europe (1). Changes in the
treatment recommendations and the increasing available
evidence have justified the implementation of new
recommendations since last Belgian consensus in 1998
(2). Several non-H. pylori Helicobacter species (NH.
PYLORI-H), colonizing the stomach of domestic animals,
also have the ability to cause gastric disease in humans,
although to a lesser extent. These zoonotic NH. PYLORIH
are not the subject of the current recommendations
chronic gastritis, peptic ulcers and gastric cancer.
Although H. pylori prevalence is decreasing worldwide,
regional variations exist in Europe, with the lowest
infection prevalence in Northern Europe, and the highest
in Eastern and Southern Europe (1). Changes in the
treatment recommendations and the increasing available
evidence have justified the implementation of new
recommendations since last Belgian consensus in 1998
(2). Several non-H. pylori Helicobacter species (NH.
PYLORI-H), colonizing the stomach of domestic animals,
also have the ability to cause gastric disease in humans,
although to a lesser extent. These zoonotic NH. PYLORIH
are not the subject of the current recommendations
Tijdschrift: Acta Gastro-Enterol Belg
ISSN: 0001-5644
Issue: 1
Volume: 86
Pagina's: 74-91
Jaar van publicatie:2023
Trefwoorden:Humans, Helicobacter pylori, Consensus, Belgium, Helicobacter Infections/drug therapy, Anti-Bacterial Agents/therapeutic use
Toegankelijkheid:Open